First interim analysis of the German prospective, non-interventional study PaVe: first results on the clinical routine of ruxolitinib in polycythemia vera

被引：0
作者：
Griesshammer, M. [1 ]
von der Heyde, E. [2 ]
Weide, R. [3 ]
Reichert, D. [4 ]
Weniger, J. [5 ]
Schlag, R.
Hutzschenreuter, U. [6 ]
Becker, M. [7 ]
Just, M.
Hacker, E. [8 ]
Cavanna, D. [8 ]
Lengfelder, E. [9 ]
机构：
[1] Johannes Wesling Klinikum, Minden, Germany
[2] Gemeinschaftspraxis Dres Zander von der Heyde, Hannover, Germany
[3] Praxisklin Hamatol & Onkol, Koblenz, Germany
[4] Onkol Gemeinschaftspraxis Dres Reichert Janssen, Westerstede, Germany
[5] Gemeinschaftspraxis Hamatol & Onkol Dres Weniger, Erfurt, Germany
[6] Hamatol Onkol Gemeinschaftspraxis Dres Hutzschenr, Nordhorn, Germany
[7] Zentrum Hamatol & Onkol MVZ GmbH, Porta Westfalica, Germany
[8] Novartis Pharma GmbH, Nurnberg, Germany
[9] Univ Med Mannheim, Med Klin 3, Mannheim, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P544
引用
收藏
页码：148 / +
页数：2
相关论文
共 50 条
  • [21] The First Results of Ruxolitinib Versus Best Available Therapy for Polycythemia Vera in Mongolia
    Gonchigdash, Chinbat
    Purevsuren, Baljinnyam
    Tungalag, Saruul
    Tungalagchimeg, Erdenechimeg
    Norov, Oyundelger
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S430 - S430
  • [22] Non-interventional study of rituximab in the treatment of Chronic Lymphocytic Leukaemia (CLL NIS): first interim results
    Reiser, M.
    Hensel, M.
    Hoesl, M.
    Janssen, J.
    Jentsch-Ullrich, K.
    Koenigsmann, M.
    Lueck, A.
    Schwarzer, A.
    Tschechne, B.
    Hechenbichler, K.
    Kellershohn, K.
    Maschmeyer, G.
    ONKOLOGIE, 2012, 35 : 217 - 217
  • [23] EFFICACY OF ETANERCEPT ON RADIOGRAPHIC PROGRESSION IN ADULT PATIENTS WITH RHEUMATOID OR PSORIATIC ARTHRITIS: RESULTS FROM THE FIRST INTERIM ANALYSIS OF A GERMAN NON-INTERVENTIONAL, PROSPECTIVE, MULTI-CENTER STUDY
    Wassenberg, S.
    Rau, R.
    Klopsch, T.
    Lippe, R.
    Lendl, U.
    Löschmann, P. -A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 715 - 716
  • [24] First interim results from a non-interventional study in hepatocellular carcinoma patients treated with sorafenib - the INSIGHT study
    Ganten, T. M.
    Schott, E.
    Goehler, T.
    Wiest, R.
    Malfertheiner, P.
    Stauber, R.
    Buder, R.
    Achilles, K.
    Gerken, G.
    ONKOLOGIE, 2011, 34 : 215 - 215
  • [25] BENDAMUSTINE-BASED FIRST LINE THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN ROUTINE CLINICAL PRACTICE: INTERIM ANALYSIS OF THE GERMAN NON-INTERVENTIONAL STUDY BE-CELL1ST
    Bruch, H. R.
    Aldaoud, A.
    Klausmann, M.
    Hansen, R.
    Losem, C.
    Frank, M.
    Strassl, L.
    Ruffert, K.
    HAEMATOLOGICA, 2014, 99 : 585 - 585
  • [26] Interim Analysis of a Non-interventional Study of Everolimus After Failure of the First Anti-VEGF Therapy
    Bergmann, L.
    Kube, U.
    Kindler, M.
    Goebell, P. J.
    Jakob, A.
    Steiner, T.
    Staehler, M.
    Overkamp, F.
    Guderian, G.
    Doehn, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S521 - S521
  • [27] Subcutaneous rituximab in patients with DLBCL and follicular NHL - First interim results from the non-interventional study MabSCale
    Duerig, J.
    Azeh, I
    Blumenstengel, K.
    Gerhardt, A.
    Haenel, M.
    Hapke, G.
    Hensel, M.
    Hessling, J.
    Hoeffkes, H. -G
    Hurtz, H. -J
    Ritter, M.
    Staib, P.
    Uhlig, J.
    Marquardt, M.
    Krumm, K.
    von Weikersthal, Fischer L.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 156 - 156
  • [28] Olaparib routine clinical practice in Germany - Quality of life interim results of the non-interventional C-PATROL study
    El-Balat, A.
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Grabowski, J. P.
    Hartkopf, A.
    Glowik, R.
    Hilpert, F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E188 - E188
  • [29] Allogeneic HSCT in patients with 17p-CLL: first results of a non-interventional prospective study
    Schetelig, J.
    Hoek, J.
    Stilgenbauer, S.
    Bornhaeuser, M.
    Andersen, N.
    Fox, C.
    Lenhoff, S.
    Bunjes, D.
    Volin, L.
    Shimoni, A.
    Schroyens, W.
    v. Gelder, M.
    van Biezen, A.
    de Wreede, L.
    De Witte, T.
    Kroeger, N.
    Dreger, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S36 - S36
  • [30] Interim results of the phase IV JAKoMo trial, a prospective, non-interventional study of symptoms and quality of life in myelofibrosis patients receiving ruxolitinib therapy
    Wehrle, J.
    Geer, T.
    Brudler, O.
    Schaefer, E.
    Tesch, H.
    Cavanna, D.
    Bachhuber, P.
    Markhauser, M.
    Koschmieder, S.
    Mesa, R. A.
    Pahl, H. L.
    Oncology Research and Treatment, 2015, 38 : 227 - 228
12345